이 에피소드에 관해
In this episode, we discuss recent analysis showing significant disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England.
We also explore how our new draft recommendations for these medications could increase uptake with our three guests.
They are: Dr Waqaar Shah, chair of the type 2 diabetes guideline committee; Dr Soon Song, consultant physician and diabetologist at Sheffield Teaching Hospitals NHS Foundation Trust; Dr Rahul Mohan, a GP and secretary of the Primary Care Diabetes Society.
Learn more about: www.nice.org.uk/news/articles/wom…r-type-2-diabetes
Read our draft guideline for type 2 diabetes medicines management: www.nice.org.uk/guidance/gid-ng10336/documents/450
We also explore how our new draft recommendations for these medications could increase uptake with our three guests.
They are: Dr Waqaar Shah, chair of the type 2 diabetes guideline committee; Dr Soon Song, consultant physician and diabetologist at Sheffield Teaching Hospitals NHS Foundation Trust; Dr Rahul Mohan, a GP and secretary of the Primary Care Diabetes Society.
Learn more about: www.nice.org.uk/news/articles/wom…r-type-2-diabetes
Read our draft guideline for type 2 diabetes medicines management: www.nice.org.uk/guidance/gid-ng10336/documents/450
영어
영국
전사 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
이 팟캐스트의 다른 에피소드
In this episode of NICE Talks, we learn the impact of the joint asthma guideline published in November 2024. Developed collaboratively by the British Thoracic Society, NICE and the Scottish Intercollegiate Guidelines Network, the guideline has transformed how asthma is diagnosed and treated across …
In this episode we learn how NICE is helping to deliver the government's 10 year health plan. Our guests are the senior responsible officers looking after the three NICE projects. They are: associate director for planning and operations Jenna Dilkes; deputy director for HealthTech Sarah Byron; and…
We look back on the guidance we've produced in 2025.
We're joined by director of medicines evaluation Helen Knight, the deputy director of the centre for guidelines Eric Power, and Anastasia Chalkidou, the programme director of guidance delivery in HealthTech.
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.
Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 National Institute of Health and Care Excellence (NICE)에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
